Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-26-032876
Filing Date
2026-07-10
Accepted
2026-07-10 17:15:24
Documents
14
Effectiveness Date
2026-07-10

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 59199
2 EX-5.1 ex5-1.htm EX-5.1 15657
3 EX-23.1 ex23-1.htm EX-23.1 3376
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 16291
5 GRAPHIC ex5-1_001.jpg GRAPHIC 9861
  Complete submission text file 0001493152-26-032876.txt   228451

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5010
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-297396 | Film No.: 261169441
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)